StemSight
Curing blindness with stem cells
Stage
Research, Pre-revenue
Business Model
B2B
Funding
Seed
Industries
Biomaterials and implants, Healthcare & Life Science
Technology
Biotechnology
Sustainable Development Goals
SDG 3 - Good Health and Well-Being
Overview
We are developing off-the-shelf cell therapies for corneal blindness using human induced pluripotent stem cells. Our firsts product aims to cure a rare form of blindness called limbal stem cell deficiency that currently can’t be cured. In the future, we aim to tackle the global corneal tissue shortage with stem cell based solutions.
Founders
Contact Information
laura.koivusalo@stemsight.fi
Media
